Add Company
Join Now

Bexson Biomedical / Ketamine Reformulation Development Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Bexson Biomedical / Ketamine Reformulation Development's estimated annual revenue is currently $3.4M per year.(i)
  • Bexson Biomedical / Ketamine Reformulation Development's estimated revenue per employee is $201,000

Employee Data

  • Bexson Biomedical / Ketamine Reformulation Development has 17 Employees.(i)
  • Bexson Biomedical / Ketamine Reformulation Development grew their employee count by 13% last year.

Bexson Biomedical / Ketamine Reformulation Development's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Sr. VP Drug DeliveryReveal Email/Phone
3
VP QualityReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Bexson Biomedical / Ketamine Reformulation Development?

Bexson Biomedical is developing non-opioid therapies for pain management. Our goal is to provide therapies that provide relief to patients and reduce the rates of opioid addiction.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$3.4M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M17-11%N/A
#2
$1.5M17-6%N/A
#3
$0.6M18-50%$23.8M
#4
N/A1829%N/A
#5
$2.4M18N/AN/A